A carregar...
Therapeutic Potential of Fluoxetine in Neurological Disorders
The selective serotonin reuptake inhibitor (SSRI) fluoxetine, which is registered for a variety of psychiatric disorders, has been found to stimulate the cAMP‐responsive element binding protein (CREB), increase the production of brain‐derived neurotrophic factor (BNDF) and the neurotrophic peptide S...
Na minha lista:
| Publicado no: | CNS Neurosci Ther |
|---|---|
| Main Authors: | , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Blackwell Publishing Inc
2008
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6494017/ https://ncbi.nlm.nih.gov/pubmed/18482027 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/j.1527-3458.2008.00040.x |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|